Abbott Laboratories (ABT)
NYSE: ABT · Real-Time Price · USD
112.47
+0.88 (0.79%)
At close: Aug 28, 2026, 4:00 PM EDT
112.20
-0.27 (-0.24%)
After-hours: Aug 28, 2026, 7:57 PM EDT
Abbott Laboratories Stock Forecast
Stock Price Forecast
According to 27 analysts polled by S&P Global, Abbott Laboratories stock has a consensus rating of "Buy" and an average price target of $120.2. The average 1-year stock price forecast is 6.87% higher than the current stock price, while the lowest is $103 (-8.42%) and the highest is $135 (+20.03%).
Price Target: $120.2 (+6.87%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Abbott Laboratories stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 16 | 16 | 16 | 17 | 16 | 17 |
| Buy | 6 | 5 | 4 | 4 | 4 | 4 |
| Hold | 7 | 7 | 7 | 7 | 7 | 6 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 29 | 28 | 27 | 28 | 27 | 27 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Buy Maintains $118 | Buy | Maintains | $118 | +4.92% | Aug 26, 2026 |
| Jefferies | Jefferies | Buy Reiterates $135 | Buy | Reiterates | $135 | +20.03% | Aug 21, 2026 |
| TD Cowen | TD Cowen | Buy Maintains $115 → $135 | Buy | Maintains | $115 → $135 | +20.03% | Aug 21, 2026 |
| BTIG | BTIG | Buy Maintains $134 | Buy | Maintains | $134 | +19.14% | Aug 21, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Maintains $115 | Buy | Maintains | $115 | +2.25% | Aug 21, 2026 |
Financial Forecast
Revenue This Year
50.30B
from 44.33B
Increased by 13.48%
Revenue Next Year
54.65B
from 50.30B
Increased by 8.63%
EPS This Year
5.52
from 5.15
Increased by 7.16%
EPS Next Year
6.06
from 5.52
Increased by 9.89%
EPS and Forward PE are based on non-GAAP adjusted numbers.